Literature DB >> 16876345

Mode of action of beta-cyclodextrin as an absorption enhancer of the water-soluble drug meglumine antimoniate.

Patrícia S Martins1, Rosemary Ochoa, Adriano M C Pimenta, Lucas A M Ferreira, Alan L Melo, José B B da Silva, Rubén D Sinisterra, Cynthia Demicheli, Frédéric Frézard.   

Abstract

It has been previously reported that beta-cyclodextrin (beta-CD) enhances the oral absorption of the pentavalent antimony (Sb) drug, meglumine antimoniate (MA). Contrary to the drugs commonly used in association with beta-CD, MA is highly soluble in water (solubility >300 mg/mL) and, therefore, the mode of action of beta-CD in this system requires clarification. ESI(-)-MS analysis of MA and of the MA/beta-CD composition indicated the formation of a 1:1 association compound between 1:1 Sb-meglumine complex and beta-CD. A stability constant on the order of 100 Lmol(-1) was determined for this association compound. When MA solution was heated for 48 h at 55 degrees C to mimic the conditions used to prepare MA/beta-CD, MA was found to suffer dissociation, from high molecular weight Sb complexes into species of lower molecular weight. Strikingly, heated MA was found to be more extensively absorbed in mice by the oral route than MA freshly prepared at room temperature. In vitro skin permeation experiments using MA and MA/beta-CD indicated a two-fold increase in the Sb flux for MA/beta-CD. These findings support the hypothesis that the improved oral absorption of Sb arises from the increased permeation of MA across lipid bilayers, as a result of the enhanced availability of 1:1 Sb-meglumine complex.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876345     DOI: 10.1016/j.ijpharm.2006.06.014

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

1.  Amphiphilic Antimony(V) Complexes for Oral Treatment of Visceral Leishmaniasis.

Authors:  Flaviana R Fernandes; Weverson A Ferreira; Mariana A Campos; Guilherme S Ramos; Kelly C Kato; Gregório G Almeida; José D Corrêa; Maria N Melo; Cynthia Demicheli; Frédéric Frézard
Journal:  Antimicrob Agents Chemother       Date:  2013-06-24       Impact factor: 5.191

2.  Effect of Different Absorption Enhancers on the Nasal Absorption of Nalmefene Hydrochloride.

Authors:  Ting Zhang; Meng Li; Xiaolu Han; Guangjun Nie; Aiping Zheng
Journal:  AAPS PharmSciTech       Date:  2022-05-16       Impact factor: 3.246

3.  Efficacy of Meglumine Antimoniate in a Low Polymerization State Orally Administered in a Murine Model of Visceral Leishmaniasis.

Authors:  Kelly C Kato; Eliane de Morais-Teixeira; Arshad Islam; M Fatima Leite; Cynthia Demicheli; Whocely V de Castro; José D Corrêa-Junior; Ana Rabello; Frédéric Frézard
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

4.  Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution.

Authors:  Laura Ceballos; Laura Moreno; Juan J Torrado; Carlos Lanusse; Luis Alvarez
Journal:  BMC Vet Res       Date:  2012-05-28       Impact factor: 2.741

5.  Cell transfection with a β-cyclodextrin-PEI-propane-1,2,3-triol nanopolymer.

Authors:  Wing-Fu Lai; Han-Sung Jung
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

Review 6.  Pentavalent antimonials: new perspectives for old drugs.

Authors:  Frédéric Frézard; Cynthia Demicheli; Raul R Ribeiro
Journal:  Molecules       Date:  2009-06-30       Impact factor: 4.411

Review 7.  Cyclodextrins in non-viral gene delivery.

Authors:  Wing-Fu Lai
Journal:  Biomaterials       Date:  2013-10-05       Impact factor: 12.479

Review 8.  Pharmacokinetics and pharmacodynamics in the treatment of cutaneous leishmaniasis - challenges and opportunities.

Authors:  Katrien Van Bocxlaer; Simon L Croft
Journal:  RSC Med Chem       Date:  2021-01-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.